Description

Adenosine A1 receptor model and its modulation by cannabidiol through equilibrative nucleoside transporter inhibition. Enhanced adenosine signaling is associated with seizure termination and neuroprotection.

Figure 167

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 167: Adenosine A1 receptor model and its modulation by cannabidiol through equilibrative nucleoside transporter inhibition. Enhanced adenosine signaling is associated with seizure termination and neuroprotection.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Adenosine A1 receptor model and its modulation by cannabidiol through equilibrative nucleoside transporter inhibition. Enhanced adenosine signaling is associated with seizure termination and neuroprotection." />
  <figcaption>Figure 167. Adenosine A1 receptor model and its modulation by cannabidiol through equilibrative nucleoside transporter inhibition. Enhanced adenosine signaling is associated with seizure termination and neuroprotection.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études